Araştırma Makalesi
BibTex RIS Kaynak Göster

PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY

Yıl 2019, , 117 - 134, 01.06.2019
https://doi.org/10.33483/jfpau.480073

Öz



Objective: Aim of the research to make forced degradation study of piperidinium
2-((5- (furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl) acetate in active pharmaceutical
ingredient
(API), 0.1% solution and 1% solution for injection. Influence of
the sodium hydroxide, hydrochloride acid, 3% Н2О2,
temperature, UV radiation on piperidine 2-((5-(furan-2-yl)
-4-phenyl-4H-1,2,4-triazol-3-yl) acetate substance, 0.1% solution and 1%
solution for injections was studied.
Material and method: Agilent 1260 Infinity HPLC System. Agilent single-quadrupole mass spectrometer 6120. Result
and discussion:
Dependence of the quantitative content of the piperidinium
2-((5-(furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl) acetate from exposition time
was determined.
The composition of impurities formed under the action of an oxidizer was
established (3%Н2О2). This is sulfoxide and sulfone
corresponding to the API.
The composition of impurities which were formed under the influence of UV
radiation was proposed.



Teşekkür

We acknowledge complete support of the Zaporozhye State Medical University. We thank rector of Zaporozhye State Medical University Prof. Yu. M. Kolesnyk for his help and support.

Kaynakça

  • Sehrawat, R., Maithani, M., Singh, R. (2010). Regulatory Aspects in Development of Stability-Indicating Methods: A Review. Chromatographia, 72 (1/2), 1–6.
  • Blessy, M, Ruchi, D. P., Prajesh, N. Pr., Agrawal Y.K. (2014). Development of forced degradation and stability indicating studies of drugs—A review. Journal of Pharmaceutical Analysis; 4(3), 159–165.
  • Klick, S., Muijselaar, P. G., Waterval J., Eichinger, Th., Korn, C., Gerding Th. K., Debets Al. J., Van de Griend C. S., Van den Beld C., Somsen G. W. and De Jong G. J. (2005). Stress Testing of Drug Substances and Drug Products. Pharmaceutical Technology, FEBRUARY; 48–66.
  • Chakravarthy, V. A., Sailaja, B. B. V., Kumar A. P. (2015). Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms. Journal of Analytical Methods in Chemistry, 1 – 11
  • Ahirrao, V. K., Patil, C. S., Bembalkar, S. R., Katariya, M. V., Sonnekar, V. S., Marathe, R. P., Nawale, R. B., Pawar, R. P. (2012). Stress degradation studies of dronedarone in pharmaceutical dosage form by a validated stability-indicating LC method. Journal of the Chilean Chemical Society,57(3); 1272 – 1276.
  • Patel, J. K., Patel, N. K. (2014). Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form. Scientia Pharmaceutica, 82, 749–763
  • Parchenko, V. (2006). Synthesis, physicochemical and biological properties of derivatives of 1,2,4-triazoles-3-thione containing core furan. Candidate of PharmSci thesis, Zaporozhye State Medical University, Zaporozhye, 208 p.
  • Parchenko, V. (2014). Synthesis, transformation, physico-chemical and biological properties in a number of 5-furyl-substituted 1,2,4-triazole-3-thiones. Dr. Pharmacist Sciences thesis, Zaporozhye State Medical University, Zaporozhye, 460 p.
  • Tietze, L.F., Eicher, Th. (1991). Reaktionen und Synthesen im organisch‐chemischen Praktikum und Forschungslaboratorium. 2. Aufl., Georg Thieme Verlag, Stuttgart – New York. DM 68, 672 S.
  • Varynskyi, B. O. (2016). Optimization of the detection conditions for the series of 1,2,4-triazole-3-thiones for FIA-ESI-MS and HPLC-ESI-MS. NEWS OF PHARMACY, 1(85), 7-11.

PİPERİDİNYUM 2-((5-(FURAN-2-İL)-4-FENİL-4H-1,2,4-TRİAZOL)-3-İL) ASETATIN ZORLANMIŞ BOZUNMA ÇALIŞMASI

Yıl 2019, , 117 - 134, 01.06.2019
https://doi.org/10.33483/jfpau.480073

Öz

        Amaç: Bu araştırmanın amacı; aktif farmasötik içerikteki (API) 2-((5-(furan-2-İl)-4-fenİl-4H-1,2,4-trİazol)-3-İl)
asetat maddesinin % 0.1 çözeltisinin ve enjeksiyonluk % 1 çözeltisinin
zorlanmış bozunmasının incelenmesidir. Çalışma, sodyum hidroksit, hidroklorik
asit,% 3 H2O2, sıcaklık ve UV radyasyonunda bulunan piperidinyum
2–((5-(furan-2-il)-4-fenil-4H-1,2,4-triazol)-3-il) asetatın % 0.1 çözelti ve
enjeksiyonluk % 1'lik çözeltisinde gerçekleştirilmiştir.

       
Gereç ve Yöntem: Agilent 1260 Infinity HPLC Sistemi. Agilent dört kutuplu kütle
spektrometresi 6120.










        Sonuç ve Tartışma: Piperidinyum 2-((5-(furan-2-il)-4-fenil-4H-1,2,4-triazol)-3-il)
asetatın kantitatif içeriğinin, maruz kalma süresine bağlı olduğu
belirlenmiştir. Oksitleyicinin (% 3 Н2О2) etkisi altında
oluşan bozunma ürünlerinin bileşimi gösterilmiştir.
UV radyasyonunun etkisi altında oluşan bozunma
ürünlerinin bileşimi önerilmiştir.
    

Kaynakça

  • Sehrawat, R., Maithani, M., Singh, R. (2010). Regulatory Aspects in Development of Stability-Indicating Methods: A Review. Chromatographia, 72 (1/2), 1–6.
  • Blessy, M, Ruchi, D. P., Prajesh, N. Pr., Agrawal Y.K. (2014). Development of forced degradation and stability indicating studies of drugs—A review. Journal of Pharmaceutical Analysis; 4(3), 159–165.
  • Klick, S., Muijselaar, P. G., Waterval J., Eichinger, Th., Korn, C., Gerding Th. K., Debets Al. J., Van de Griend C. S., Van den Beld C., Somsen G. W. and De Jong G. J. (2005). Stress Testing of Drug Substances and Drug Products. Pharmaceutical Technology, FEBRUARY; 48–66.
  • Chakravarthy, V. A., Sailaja, B. B. V., Kumar A. P. (2015). Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms. Journal of Analytical Methods in Chemistry, 1 – 11
  • Ahirrao, V. K., Patil, C. S., Bembalkar, S. R., Katariya, M. V., Sonnekar, V. S., Marathe, R. P., Nawale, R. B., Pawar, R. P. (2012). Stress degradation studies of dronedarone in pharmaceutical dosage form by a validated stability-indicating LC method. Journal of the Chilean Chemical Society,57(3); 1272 – 1276.
  • Patel, J. K., Patel, N. K. (2014). Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form. Scientia Pharmaceutica, 82, 749–763
  • Parchenko, V. (2006). Synthesis, physicochemical and biological properties of derivatives of 1,2,4-triazoles-3-thione containing core furan. Candidate of PharmSci thesis, Zaporozhye State Medical University, Zaporozhye, 208 p.
  • Parchenko, V. (2014). Synthesis, transformation, physico-chemical and biological properties in a number of 5-furyl-substituted 1,2,4-triazole-3-thiones. Dr. Pharmacist Sciences thesis, Zaporozhye State Medical University, Zaporozhye, 460 p.
  • Tietze, L.F., Eicher, Th. (1991). Reaktionen und Synthesen im organisch‐chemischen Praktikum und Forschungslaboratorium. 2. Aufl., Georg Thieme Verlag, Stuttgart – New York. DM 68, 672 S.
  • Varynskyi, B. O. (2016). Optimization of the detection conditions for the series of 1,2,4-triazole-3-thiones for FIA-ESI-MS and HPLC-ESI-MS. NEWS OF PHARMACY, 1(85), 7-11.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Eczacılık ve İlaç Bilimleri
Bölüm Araştırma Makalesi
Yazarlar

Borys Varynskyi

Yayımlanma Tarihi 1 Haziran 2019
Gönderilme Tarihi 7 Kasım 2018
Kabul Tarihi 1 Mart 2019
Yayımlandığı Sayı Yıl 2019

Kaynak Göster

APA Varynskyi, B. (2019). PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY. Journal of Faculty of Pharmacy of Ankara University, 43(2), 117-134. https://doi.org/10.33483/jfpau.480073
AMA Varynskyi B. PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY. Ankara Ecz. Fak. Derg. Haziran 2019;43(2):117-134. doi:10.33483/jfpau.480073
Chicago Varynskyi, Borys. “PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY”. Journal of Faculty of Pharmacy of Ankara University 43, sy. 2 (Haziran 2019): 117-34. https://doi.org/10.33483/jfpau.480073.
EndNote Varynskyi B (01 Haziran 2019) PIPERIDINIUM 2-(5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY. Journal of Faculty of Pharmacy of Ankara University 43 2 117–134.
IEEE B. Varynskyi, “PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY”, Ankara Ecz. Fak. Derg., c. 43, sy. 2, ss. 117–134, 2019, doi: 10.33483/jfpau.480073.
ISNAD Varynskyi, Borys. “PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY”. Journal of Faculty of Pharmacy of Ankara University 43/2 (Haziran 2019), 117-134. https://doi.org/10.33483/jfpau.480073.
JAMA Varynskyi B. PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY. Ankara Ecz. Fak. Derg. 2019;43:117–134.
MLA Varynskyi, Borys. “PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY”. Journal of Faculty of Pharmacy of Ankara University, c. 43, sy. 2, 2019, ss. 117-34, doi:10.33483/jfpau.480073.
Vancouver Varynskyi B. PIPERIDINIUM 2-((5-(FURAN-2-YL)-4-PHENYL-4H-1,2,4-TRIAZOL)-3- YL) ACETATE FORCED DEGRADATION STUDY. Ankara Ecz. Fak. Derg. 2019;43(2):117-34.

Kapsam ve Amaç

Ankara Üniversitesi Eczacılık Fakültesi Dergisi, açık erişim, hakemli bir dergi olup Türkçe veya İngilizce olarak farmasötik bilimler alanındaki önemli gelişmeleri içeren orijinal araştırmalar, derlemeler ve kısa bildiriler için uluslararası bir yayım ortamıdır. Bilimsel toplantılarda sunulan bildiriler supleman özel sayısı olarak dergide yayımlanabilir. Ayrıca, tüm farmasötik alandaki gelecek ve önceki ulusal ve uluslararası bilimsel toplantılar ile sosyal aktiviteleri içerir.